Skip to main content
. 2023 Oct 2;109(5):1107–1112. doi: 10.4269/ajtmh.23-0431

Table 4.

Suspected erm mutation prevalence in study arms at 36 months

Resistance profile Number of mutations in azithromycin arm (% phenotype) Number of mutations in placebo arm (% phenotype)
Erythromycin and clindamycin 11 (58) 8 (42)
Erythromycin only 12 (60) 8 (40)
Clindamycin only* 1 (100) 0 (0)
None 123 (42) 169 (58)
147 185
*

Removed from regression models.